KDM2BSynovial Cancer: KDM2B is required for proliferation independently of demethylase activity (>90% of these cancers). Pancreatic Cancer: KDM2B can activate genes involved in ribosomal and mitochondrial function. This evidence concerns the gene KDM2B and familial pancreatic carcinoma.